CNX Therapeutics Limited is a privately held limited company established in 1997, operating from its headquarters at 3 Bunhill Row, London, EC1Y 8YZ. The company’s core business centers around the exploration, development, and production of natural gas, with a particular emphasis on sustainable energy initiatives. CNX is dedicated to utilizing low-carbon shale gas resources to minimize environmental impact. As a specialist in natural gas, CNX’s activities encompass the entire value chain, from initial exploration and assessment to extraction and processing. The company’s strategic focus is on securing and managing rights to significant shale gas reserves, contributing to a reduction in greenhouse gas emissions. CNX Therapeutics operates internationally, though its primary operational base remains in the United Kingdom. The company’s SIC codes reflect its industry focus, encompassing both natural gas extraction and distribution, as well as related services. CNX Therapeutics is currently employing a skilled workforce, with a Worker rating indicating a focus on operational tasks. The company is actively pursuing international partnerships and investments to expand its reach and contribute to a greener energy future.

CNX Therapeutics Limited is a privately held limited company established in 1997, operating from its headquarters at 3 Bunhill Row, London, EC1Y 8YZ. The company’s core business centers around the exploration, development, and production of natural gas, with a particular emphasis on sustainable energy initiatives. CNX is dedicated to utilizing low-carbon shale gas resources to minimize environmental impact. As a specialist in natural gas, CNX’s activities encompass the entire value chain, from initial exploration and assessment to extraction and processing. The company’s strategic focus is on securing and managing rights to significant shale gas reserves, contributing to a reduction in greenhouse gas emissions. CNX Therapeutics operates internationally, though its primary operational base remains in the United Kingdom. The company’s SIC codes reflect its industry focus, encompassing both natural gas extraction and distribution, as well as related services. CNX Therapeutics is currently employing a skilled workforce, with a Worker rating indicating a focus on operational tasks. The company is actively pursuing international partnerships and investments to expand its reach and contribute to a greener energy future.